- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03956238
Alcohol Myopia, Objectification, and Sexual Assault
July 6, 2023 updated by: University of Nebraska Lincoln
Integrating Alcohol Myopia and Objectification to Understand Sexual Assault
The present project integrates previous research on factors associated with alcohol-involved sexual assault, with research on how intoxication alters attention and social perceptions in ways that increase the risk of sexual aggression and victimization.
Specifically, this project examines whether alcohol intoxication on the part of a male perpetrator impairs attentional capacity and leads to a narrowing of the perceptual field causing a dehumanizing perspective of women as sexual objects for men's pleasure rather than individuals with thoughts and feelings, thereby increasing the propensity for sexual aggression.
The present research also examines whether women's responses to this sexual objectification from men interfere with risk perception in sexual situations, particularly when women are drinking, increasing the likelihood of sexual victimization.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
These studies will provide a comprehensive test of our proposed model of alcohol-involved sexual assault that includes situation-specific mechanisms and key moderators of sexual violence.
Specifically, hypotheses will be tested in the context of two carefully controlled laboratory studies.
In Study 1, laboratory alcohol administration procedures will be used to manipulate intoxication (vs.
placebo control) in men.
Impaired attention and objectification will then be measured multi-modally including behavioral, self-report, and implicit measures.
Finally, sexual aggression will be measured with a laboratory-based analogue of sexual assault.
Study 2 will include women and follow the same alcohol administration procedures as Study 1.
Additionally, mirroring men's objectification, objectifying gazes (vs.
eye gazes) will also be manipulated.
Impaired attention, self-objectification, and decreased sexual risk perceptions will then be assessed.
Prior the laboratory visit, all participants will complete a battery of questionnaires to assess key moderators including a history of sexual assault perpetration and victimization, prior sexual objectification and self-objectification, as well as alcohol-related sex expectances and rape myth acceptance.
The overall model will be analyzed within a conditional process model framework.
Study Type
Interventional
Enrollment (Actual)
359
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sarah Gervais, PhD
- Phone Number: 402-472-3721
- Email: sgervais2@unl.edu
Study Contact Backup
- Name: David DiLillo, PhD
- Phone Number: 402-472-3297
- Email: ddilillo2@unl.edu
Study Locations
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68588
- University of Nebraska-Lincoln
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 28 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 21-30 years of age
- at least social drinkers
- single
- men attracted to women, women attracted to men
Exclusion Criteria:
- current/past alcohol dependence (as assessed by a score of 8 or higher on the Alcohol Dependence Scale), alcohol-related treatment, or hospitalization due to alcohol use
- any past serious head injuries (as indicated by HELPS Brain Injury Screening Tool)
- serious psychological symptoms (defined as past psychotic, paranoid, or bipolar disorders, or current major depression)
- abstinence from alcohol use
- a condition or medication use in which alcohol consumption is medically contraindicated
- any legal restriction against drinking (e.g., as condition of probation or parole)
- presence of a positive breath alcohol concentration (BAC) upon arrival to the laboratory
- if the participant is less than six feet tall and weighs over 250 pounds or is over six feet tall and weighs over 300 pounds
- if a female participant is pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Males and Alcohol Intoxication
Men assigned to alcohol intoxication arm (target BAC .08%)
|
Men and women assigned to moderate alcohol dose condition (target BAC .08%)
or placebo control condition with NIAAA approved alcohol administration procedures
|
Placebo Comparator: Males and Placebo Control
Men assigned to placebo control arm
|
Men and women assigned to moderate alcohol dose condition (target BAC .08%)
or placebo control condition with NIAAA approved alcohol administration procedures
|
Experimental: Females and Alcohol Intoxication and Objectifying Gazes
Women assigned to alcohol intoxication arm (target BAC .08%)
and objectifying gazes arm
|
Men and women assigned to moderate alcohol dose condition (target BAC .08%)
or placebo control condition with NIAAA approved alcohol administration procedures
Women assigned to objectifying gazes condition or eye contact control condition
|
Experimental: Females and Alcohol Intoxication and Eye Gazes
Women assigned to alcohol intoxication arm (target BAC .08%)
and eye gazes arm
|
Men and women assigned to moderate alcohol dose condition (target BAC .08%)
or placebo control condition with NIAAA approved alcohol administration procedures
Women assigned to objectifying gazes condition or eye contact control condition
|
Experimental: Females and Placebo Control and Objectifying Gazes
Women assigned to placebo control arm and objectifying gazes arm
|
Men and women assigned to moderate alcohol dose condition (target BAC .08%)
or placebo control condition with NIAAA approved alcohol administration procedures
Women assigned to objectifying gazes condition or eye contact control condition
|
Placebo Comparator: Females and Placebo Control and Eye Gazes
Women assigned to placebo control arm and eye gazes arm
|
Men and women assigned to moderate alcohol dose condition (target BAC .08%)
or placebo control condition with NIAAA approved alcohol administration procedures
Women assigned to objectifying gazes condition or eye contact control condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Laboratory analogue of sexual aggression
Time Frame: 20 minutes post alcohol or placebo dosing
|
After learning that a woman does not like sexual media, male participants choose to show her a sexually explicit video or control video (selection of the sexually explicit video indicates more sexual aggression)
|
20 minutes post alcohol or placebo dosing
|
Sexual assault vignette measure of risk perception
Time Frame: 20 minutes post alcohol or placebo dosing
|
Female participants read 18 vignettes describing a sexual interaction between a man and a woman that gets progressively riskier for sexual assault and indicate when they would leave the interaction (scores range from 1-18 and higher scores indicate worse risk perception)
|
20 minutes post alcohol or placebo dosing
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Eye-tracking measure of sexual objectification
Time Frame: 2 minutes post alcohol or placebo dosing
|
Male participants wear a portable eye tracker and discuss media preferences with a female confederate while dwell time on the female confederate's face and body is monitored (longer dwell times on the woman's body and shorter dwell times on the woman's face indicate more sexual objectification)
|
2 minutes post alcohol or placebo dosing
|
Eye-tracking measure of self-objectification
Time Frame: 2 minutes post alcohol or placebo dosing
|
Female participants wear a portable eye tracker and interact with a male confederate in front of a mirror while dwell time on the participant's body is monitored (longer dwell times on the participant's body indicates more self-objectification)
|
2 minutes post alcohol or placebo dosing
|
Object brief-implicit association task
Time Frame: 25 minutes post alcohol or placebo dosing
|
On a computer, male participants sort stimuli words representing the categories object (e.g., tool), human (e.g., person), women (e.g., female), and men (male).
Participants must respond as quickly and accurately as possible to categorize the words on a computer screen to object, human, women, and men categories via a computer key press.
Responding faster to object and woman words and slower to woman and human words indicates implicit objectification of women
|
25 minutes post alcohol or placebo dosing
|
Self-object brief-implicit association task
Time Frame: 25 minutes post alcohol or placebo dosing
|
On a computer, female participants sort stimuli words representing the categories object (e.g., tool), human (e.g., person), me (e.g., self), and others (them).
Participants must respond as quickly and accurately as possible to categorize the words on a computer screen to object, human, me, and others categories via a computer key press.
Responding faster to object and me words and slower to human and me words indicates implicit self-objectification.
|
25 minutes post alcohol or placebo dosing
|
Self-report state mindful attention awareness scale
Time Frame: 30 minutes post alcohol or placebo dosing
|
Male and female participants self-report how attentive they feel on a 0 to 6 point scale (averaged lower scores indicate more mindful attention awareness)
|
30 minutes post alcohol or placebo dosing
|
Self-report other-objectification questionnaire
Time Frame: 35 minutes post alcohol or placebo dosing
|
Male participants self-report how frequently they objectified the female confederate on a 1 to 6 point scale (averaged higher scores indicate more other-objectification)
|
35 minutes post alcohol or placebo dosing
|
Self-report self-objectification questionnaire
Time Frame: 35 minutes post alcohol or placebo dosing
|
Female participants self-report how important appearance related attributes (e.g., sex appeal) are important to their self-concept relative to non-appearance attributes (e.g., hobbies) on a 0 to 9 point scale.
Appearance attributes and non-appearance attributes are separately summed and non-appearance attribute scores are subtracted from appearance attribute scores (higher scores indicate more self-objectification)
|
35 minutes post alcohol or placebo dosing
|
Saliva collection
Time Frame: 5 minutes pre alcohol or placebo dosing, 5 minutes post alcohol dosing, and 20 minutes post alcohol or placebo dosing
|
Female participants provide saliva samples to assess cortisol associated with stress responses
|
5 minutes pre alcohol or placebo dosing, 5 minutes post alcohol dosing, and 20 minutes post alcohol or placebo dosing
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sarah Gervais, PhD, University of Nebraska Lincoln
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 22, 2019
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
May 2, 2019
First Submitted That Met QC Criteria
May 17, 2019
First Posted (Actual)
May 20, 2019
Study Record Updates
Last Update Posted (Actual)
July 10, 2023
Last Update Submitted That Met QC Criteria
July 6, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18599 (UKCLRN)
- R01AA025090 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified individual participant data may be shared with other researchers (e.g., posted to the Open Science Framework) to aid with reproducibility and replicability of science.
IPD Sharing Time Frame
De-identified data may be made available to interested researchers when papers based on that data are published in scientific journals.
IPD Sharing Access Criteria
Interested researchers will be required to have an Open Science Framework account.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcoholic Intoxication
-
Massachusetts General HospitalNational Institute on Drug Abuse (NIDA)CompletedIntoxication Alcohol | Intoxication THC | Intoxication Combined Alcohol THCUnited States
-
University of KonstanzCompletedAlcoholic Intoxication, ChronicGermany
-
Assistance Publique - Hôpitaux de ParisInstitut de Recherches Scientifiques sur les BoissonsCompletedAlcoholic Intoxication, ChronicFrance
-
Medical University of ViennaUnknownPerceived Alcohol IntoxicationAustria
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingAlcohol Intoxication | Cannabis IntoxicationUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Not yet recruitingAlcohol Intoxication | Cannabis IntoxicationUnited States
-
Centre Hospitalier Universitaire DijonCompletedAlcoholic Intoxication, ChronicFrance
-
Mclean HospitalRecruitingAlcohol IntoxicationUnited States
-
RRF Field Services LLCPacific Institute for Research and EvaluationCompleted
-
University Health Network, TorontoThornhill MedicalUnknown
Clinical Trials on Alcohol intoxication
-
Georgia State UniversityRecruitingAlcohol IntoxicationUnited States
-
Georgia State UniversityUniversity of Nebraska LincolnRecruitingSexual Violence | Alcohol Intoxication | Helping BehaviorUnited States
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR)Completed
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPatent Ductus ArteriosusNetherlands, Belgium
-
Eisai LimitedCompletedCentral Nervous SystemUnited Kingdom
-
University of Illinois at Urbana-ChampaignCarle Foundation HospitalTerminated
-
National Institute on Alcohol Abuse and Alcoholism...Recruiting
-
University of California, San FranciscoCompletedHIV Infections | Hepatitis CUnited States
-
Brown UniversityCompleted
-
Brown UniversityUnknownBinge Drinking | Sexually Transmitted Diseases | HIV/AIDS | Unsafe SexUnited States